Marrakchi N, Barbouche R, Guermazi S, Bon C, el Ayeb M
Laboratoire des Venins et Toxines, Institut Pasteur de Tunis, Belvédère, Tunisia.
Toxicon. 1997 Feb;35(2):261-72. doi: 10.1016/s0041-0101(96)00116-x.
Cerastocytin is a thrombin-like serine protease with potent platelet-proaggregating properties. It is able to activate factor XIII but is less active than thrombin on plasma coagulation. The aggregation induced by cerastocytin resembles that induced by thrombin, since rabbit washed platelets desensitized by a pretreatment with thrombin do not aggregate in the presence of cerastocytin. Furthermore, preincubation of platelets with monoclonal antibodies specific for glycoproteins GPIb or GPIIbIIIa blocks receptor sites for thrombin and fibrinogen, respectively, and prevents their aggregation induced by thrombin or cerastocytin. A monoclonal antibody, inhibitor of von Willebrand factor (VWF)-dependent agglutination, blocks the aggregation induced by cerastocytin. After activation with cerastocytin, washed rabbit platelets degranulate and secrete ATP and phospholipase A2. However, cerastocytin is less potent in inducing the release of phospholipase A2 than in inducing ATP secretion.
蛇毒促凝酶是一种具有强力血小板聚集特性的凝血酶样丝氨酸蛋白酶。它能够激活因子XIII,但在血浆凝固方面比凝血酶活性更低。蛇毒促凝酶诱导的聚集类似于凝血酶诱导的聚集,因为经凝血酶预处理脱敏的兔洗涤血小板在蛇毒促凝酶存在下不会聚集。此外,用针对糖蛋白GPIb或GPIIbIIIa的单克隆抗体对血小板进行预孵育,分别阻断了凝血酶和纤维蛋白原的受体位点,并防止了它们由凝血酶或蛇毒促凝酶诱导的聚集。一种单克隆抗体,即血管性血友病因子(VWF)依赖性凝集抑制剂,可阻断蛇毒促凝酶诱导的聚集。用蛇毒促凝酶激活后,兔洗涤血小板脱颗粒并分泌ATP和磷脂酶A2。然而,蛇毒促凝酶在诱导磷脂酶A2释放方面比诱导ATP分泌的效力更低。